Eurobio Scientific SA (ALERS) — Capital Reinvestment Ratio
Latest as of June 2025:
0.28x
Eurobio Scientific SA (ALERS) has a Capital Reinvestment Ratio of 0.28x as of June 2025, meaning it reinvests 0% of its operating cash flow (€5.36 Million) in capital expenditures (€1.50 Million). See Eurobio Scientific SA free cash flow generation to measure how efficiently the company converts operating cash flow to free cash.
Capital Reinvestment Ratio
0.28x
Capex / Operating Cash Flow
Operating Cash Flow
€5.36 Million
EUR
Capital Expenditures
€1.50 Million
EUR
Data as of
Jun 2025
Most recent filing
Eurobio Scientific SA Capital Reinvestment Ratio (2017–2024)
This chart tracks Eurobio Scientific SA's Capital Reinvestment Ratio across 7 annual periods.
Annual Capital Reinvestment Ratio for Eurobio Scientific SA (2017–2024)
Year-by-year Capital Reinvestment Ratio for Eurobio Scientific SA from 2017 to 2024. For live market cap and broader valuation context, see ALERS stock market capitalisation.
| Year | Reinvestment Ratio | Operating CF (EUR) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2024 | 0.19x | €16.70 Million | €3.26 Million | ▲ +28.7% |
| 2023 | 0.15x | €26.77 Million | €4.05 Million | ▲ +130.2% |
| 2022 | 0.07x | €43.07 Million | €2.83 Million | ▲ +134.8% |
| 2021 | 0.03x | €65.92 Million | €1.85 Million | ▼ -33.0% |
| 2020 | 0.04x | €54.93 Million | €2.30 Million | ▼ -86.9% |
| 2019 | 0.32x | €4.99 Million | €1.59 Million | ▼ -79.8% |
| 2017 | 1.58x | €2.48 Million | €3.91 Million | — |
Capital Reinvestment Ratio = ABS(Capital Expenditures) / Operating Cash Flow